Tailored Vaccine Messaging for Parents/Caregivers of Adolescents

Study acronym: VACCINE-WEST
StatusNot Yet Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
his study will evaluate whether tailored vaccine messaging improves vaccination-related outcomes among parents and caregivers of adolescents. Participants will complete a baseline electronic survey and will then be randomly assigned to receive either a tailored vaccine message based on insurance status or a standard vaccine message delivered by SMS text message. Approximately four weeks after receiving the intervention message, participants will complete a follow-up electronic survey assessing vaccination behaviors, vaccination intentions, vaccine confidence, perceived barriers to adolescent vaccination, and perceptions of the intervention message.
Trial Details
NCT Number NCT07878442
Lead Sponsor University of Utah
Collaborators: Merck & Co., Inc.; Huntsman Cancer Institute's Intermountain West HPV Vaccination Coalition.
Conditions
(from sponsor)		 Vaccine Confidence, Adolescent Vaccination, Vaccine Uptake
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov